Del Carmen Jeffrey
Insider CIK 1816477 · CPRX Chief Commercial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 32,257 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 11,206 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 8,039 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 106,873 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 137,553 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 167,918 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 88,000 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 135,000 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 200,000 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer deriv | 2026-07-15 | 2026-07-17 | 150,000 | — | $0 | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | D To issuer | 2026-07-15 | 2026-07-17 | 14,337 | $31.50 | $451.6K | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-12-29 | 2025-12-30 | 8,667 | — | $0 | 1,036,846 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2025-12-29 | 2025-12-30 | 3,839 | — | $0 | 14,337 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-12-29 | 2025-12-30 | 8,667 | — | $0 | 18,176 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-12-08 | 2025-12-10 | 8,039 | — | $0 | 1,045,513 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-12-08 | 2025-12-10 | 8,039 | — | $0 | 12,001 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2025-12-08 | 2025-12-10 | 2,492 | — | $0 | 9,509 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-11-26 | 2025-11-28 | 10,983 | — | $0 | 1,053,552 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-11-26 | 2025-11-28 | 10,983 | $4.21 | $46.2K | 14,945 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2025-11-26 | 2025-11-28 | 10,983 | $23.33 | $256.2K | 3,962 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-11-21 | 2025-11-24 | 5,603 | — | $0 | 1,064,535 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-11-21 | 2025-11-24 | 5,603 | — | $0 | 5,603 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2025-11-21 | 2025-11-24 | 1,641 | — | $0 | 3,962 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2025-11-20 | 2025-11-24 | 32,257 | — | $0 | 1,070,138 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2025-11-20 | 2025-11-24 | 106,873 | — | $0 | 1,037,881 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2025-03-03 | 2025-03-05 | 30,423 | $22.89 | $696.4K | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-02-14 | 2025-02-19 | 10,667 | — | $0 | 931,008 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-02-14 | 2025-02-19 | 10,667 | — | $0 | 33,548 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2025-02-14 | 2025-02-19 | 3,125 | — | $0 | 30,423 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-12-27 | 2024-12-31 | 8,667 | — | $0 | 941,675 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-12-27 | 2024-12-31 | 8,667 | — | $0 | 26,720 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2024-12-27 | 2024-12-31 | 3,839 | — | $0 | 22,881 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-12-09 | 2024-12-11 | 8,039 | — | $0 | 950,342 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2024-12-09 | 2024-12-11 | 2,355 | — | $0 | 18,053 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-12-09 | 2024-12-11 | 8,039 | — | $0 | 20,408 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2024-11-21 | 2024-11-25 | 16,809 | — | $0 | 958,381 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2024-11-21 | 2024-11-25 | 137,553 | — | $0 | 941,572 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-08-09 | 2024-08-13 | 30,000 | — | $0 | 804,019 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-08-09 | 2024-08-13 | 30,000 | $2.86 | $85.8K | 42,369 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2024-08-09 | 2024-08-13 | 30,000 | $18.42 | $552.6K | 12,369 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2024-08-09 | 2024-08-13 | 6,058 | $18.44 | $111.7K | 12,369 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2024-06-07 | 2024-06-11 | 7,541 | $16.07 | $121.2K | 18,427 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-02-15 | 2024-02-16 | 10,667 | — | $0 | 834,019 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-02-15 | 2024-02-16 | 10,667 | — | $0 | 29,093 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2024-02-15 | 2024-02-16 | 3,125 | — | $0 | 25,968 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2023-12-27 | 2023-12-29 | 8,666 | — | $0 | 844,686 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2023-12-27 | 2023-12-29 | 3,839 | — | $0 | 18,426 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2023-12-27 | 2023-12-29 | 8,666 | — | $0 | 22,265 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2023-12-08 | 2023-12-12 | 24,117 | — | $0 | 853,352 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2023-12-08 | 2023-12-12 | 167,918 | — | $0 | 829,235 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2023-06-27 | 2023-06-29 | 10,000 | — | $0 | 661,317 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2023-06-27 | 2023-06-29 | 3,942 | — | $0 | 13,599 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2023-06-27 | 2023-06-29 | 10,000 | — | $0 | 17,541 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2023-03-29 | 2023-03-30 | 19,017 | — | $0 | 671,317 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2023-03-29 | 2023-03-30 | 20,983 | — | $0 | 690,334 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2023-03-29 | 2023-03-30 | 20,983 | $2.24 | $47.0K | 28,524 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2023-03-29 | 2023-03-30 | 20,983 | $16.70 | $350.4K | 7,541 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2023-03-29 | 2023-03-30 | 19,017 | $4.21 | $80.1K | 26,558 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2023-03-29 | 2023-03-30 | 19,017 | $16.69 | $317.4K | 7,541 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2023-02-15 | 2023-02-17 | 10,666 | — | $0 | 711,317 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2023-02-15 | 2023-02-17 | 10,666 | — | $0 | 10,666 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2023-02-15 | 2023-02-17 | 3,125 | — | $0 | 7,541 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2022-12-27 | 2022-12-29 | 88,000 | — | $0 | 695,983 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2022-12-27 | 2022-12-29 | 26,000 | — | $0 | 721,983 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2022-11-11 | 2022-11-15 | 120,000 | — | $0 | 627,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2022-11-11 | 2022-11-15 | 19,017 | — | $0 | 607,983 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2022-11-11 | 2022-11-15 | 120,000 | $2.86 | $343.2K | 120,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2022-11-11 | 2022-11-15 | 120,000 | $16.23 | $1.95M | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2022-11-11 | 2022-11-15 | 19,017 | $2.24 | $42.6K | 19,017 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2022-11-11 | 2022-11-15 | 19,017 | $15.46 | $294.0K | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2022-08-19 | 2022-08-22 | 14,140 | $14.05 | $198.7K | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2022-06-28 | 2022-06-30 | 10,000 | — | $0 | 747,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2022-06-28 | 2022-06-30 | 10,000 | — | $0 | 17,070 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2022-06-28 | 2022-06-30 | 2,930 | — | $0 | 14,140 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2022-02-14 | 2022-02-16 | 32,000 | — | $0 | 757,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2021-12-28 | 2021-12-30 | 135,000 | — | $0 | 725,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2021-06-24 | 2021-06-25 | 10,000 | — | $0 | 463,334 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2021-06-24 | 2021-06-25 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | F Tax w/h | 2021-06-24 | 2021-06-25 | 2,930 | — | $0 | 7,070 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2020-12-30 | 2021-01-04 | 200,000 | — | $0 | 600,000 | SEC↗ |